v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 234 $ 0 $ 424 $ 0
Cost of revenue:        
Total cost of revenue 24 0 39 0
Operating expenses:        
Research and development 10,176 9,605 29,496 31,535
Selling, general and administrative 6,771 5,867 19,513 19,878
Total operating expenses 16,947 15,472 49,009 51,413
Other income (expense):        
Interest income 1,173 1,903 3,922 6,214
Other expense (72) (5) (100) (21)
Total other income 1,101 1,898 3,822 6,193
Net loss $ (15,636) $ (13,574) $ (44,802) $ (45,220)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.12) $ (0.11) $ (0.35) $ (0.36)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.12) $ (0.11) $ (0.35) $ (0.36)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 127,238,065 126,305,122 127,005,067 126,218,587
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 127,238,065 126,305,122 127,005,067 126,218,587
Grant revenue        
Revenue:        
Total revenue $ 208 $ 0 $ 388 $ 0
Service revenue        
Revenue:        
Total revenue 26 0 36 0
Cost of revenue:        
Total cost of revenue $ 24 $ 0 $ 39 $ 0